MURIEL BOWSER
MAYOR
June 15, 2023
The Honorable Phil Mendelson
Chairman
Council of the District of Columbia
John A. Wilson Building
1350Pennsylvania Avenue, NW, Suite 504
Washington, DC 20004
Dear Chairman Mendelson:
In accordance with section 2 ofthe Confirmation Act of 1978, effective March 3, 1979 (D.C. Law
2-142; D.C. Official Code§ 1-523.01), and pursuant to section 4603 of the Child Fatality Review
Committee Establishment Act of 2001, effective October 3, 2001 (D.C. Law 14-28; D.C. Official
Code§ 4-1371.03), I am pleased to nominate the following person:
Dr. Jacqueline Francis
12th Street NE
Washington, D.C. 20002
(Ward 6)
for reappointment as a community representative member of the Child Fatality Review Committee,
for a term to end July 16, 2025.
Enclosed you will find biographical information detailing the experience of the above-
mentioned nominee, together with a proposed resolution to assist the Council during the
confirmation process.
I would appreciate the Council's earliest consideration of this nomination for confirmation.
Please do not hesitate to contact me, or Steven Walker, Director, Mayor's Office of Talent
and Appointments, should the Council require additional information.
 1
2
3
~~~
at the request of the Mayor
4
5
6 A PROPOSED RESOLUTION
7
8
9 IN THE COUNCIL OF THE DISTRICT OF COLUMBIA
10
11
12
13
14
15
16 To confirm the reappointment of Dr. Jacqueline Francis to the Child Fatality Review Committee.
17
18 RESOLVED, BY THE COUNCIL OF THE DISTRICT OF COLUMBIA, That this
19 resolution may be cited as the "Child Fatality Review Committee Dr. Jacqueline Francis
20 Confirmation Resolution of 2023".
21
22 Sec. 2. The Council of the District of Columbia confirms the reappointment of:
23
24 Dr. Jacqueline Francis
25 12th Street NE
2.6 Washington, D.C. 20002
27 (Ward 6)
28
29 as a community representative member of the Child Fatality Review Committee, pursuant to
30 section 4603 of the Child Fatality Review Committee Establishment Act of 2001, effective
31 October 3, 2001 (D.C. Law 14-28; D.C. Official Code§ 4-1371.03), and in accordance with
32 section 2 of the Confirmation Act of 1978, effective March 3, 1979 (D.C. Law 2-142; D.C.
33 Official Code§ 1-523.01), for a term to end July 16, 2025.
34 Sec. 3. The Council of the District of Columbia shall transmit a copy of this resolution,
35 upon its adoption, to the nominee and to the Office of the Mayor.
36 Sec. 4. This resolution shall take effect immediately.
37
Jacqueline Nicole Francis, MD, MPH
OBJECTIVES: To serve as a health advocate.
WORKEXPERIENCE
Acting Chief Pediatric Medical Officer Silver Spring, l\,ID .Apr. 2012-2013
Serving as chief pediatric physician expert in the Center for Devices and Radiological Health. Represents the
Center on pediatri<:: medical device related issues. Drafting guidance documents related to Pediatric Medical
Device Tracking, Custom Devices, HDE legislation and Extrapolation of adult data for pediatric device
indications. Coordinates initiatives and oversees execution ofactivities related to pediatric device issues.
Planned and exe<::uted the Rare Diseases Workshop to address pediatric issues related to the development of
medical devices used for rare diseases Qanuary 8, 2014). Works with the Pediatric Device Consortium (FDA)
to conduct workshops for grant recipients, collaborated on the drafting of the grant application/FR notice
and will oversee selection of grant recipients. Represents FD.A and expert on pediatric device development
and regulation.
Medical Officer Silver Spring, MD Sept. 2006-to date
Clinical consultant to Plastic: Surgery and Reconstruction Branch of the Office of Device Evaluation in the
Center for Devices and Radiological Health at the Food and Drug ..Administration. This division evaluates
and dears plastic surgery diagnostic and therapeutic devices. Served as clinical consultant to other branches
for a variety of devices including neurological, orthopedic, and general surgery devices with pediatric
indications.
Collaborative Reviewer Rockville, MD 2007-2010
Served as a collaborative reviewer \,Vith the Office of Patient Safety with the Medsun pilot project and
working to launch KIDNET (adverse event reporting system for pediatric devices). Represented FDA,
Presented abstract poster on the K.IDNET program at the American Academy of Pediatrics Annual meeting
October 2008. to educate pediatricians about the KIDNET program.
Attending Physician Washington, DC Jan. 2005 to date
KIDS Mobile Medical Clinic pediatrician working in medically underserved areas of Washington, DC each
Friday as primary pediatrician. Also serving on the teaching staff supervising training of residents and
medical students. Credentialed at Georgetown University Hospital.
Medical Officer Rockville, MD 2004- Sept 2006
Clinical consultant to the :tvficrobiology and Chemistry divisions in the Office of In Vitro Diagnostic Device
Evaluation and Safety in the Center for Devices and Radiological Health at the Food and Drug
Administration. This division evaluates and clears infectious disease and chemistry in vitro diagnostic
devices. Appointed as the Oirector of the Patient Safety Committee, which monitors safety of devices in
post marketing.
Attending Physician Washington, DC 4-\pr. 2004 to date
Well baby nursery and special care nursery attending physican. Admitting, discharging ,and identifying
neonates at risk for illness and congenital health issues. Credentialed at Sibley and Georgetown University
Hospitals.
Attending Physician Washington, DC
Children's Health Project of DC pediatrician working in medically underserved areas ofWashington, DC.
EDUCATION
Johns Hopkins University Medical Center Baltimore, MD 2001-2003
Resident in Preventive Medicine. Successfully completed rotations at Occupational Safety and Health
Administration (OSHA) Dept. of Occupational Medicine); the District of Columbia Dept. of Health
(Division of Communicable Diseases); the US Food and Dtug Administration (FDA, Dept. of Vaccine
Safety, Smallpox Vaccine Surveillance Team); the Department of Juvenile Justice (DJJ) Health division;
and the \XIHO /JHU dept. of Infectious Diseases in Cameroon on measles surveillance and prevention.
Johns Hopkins University Baltimore, MD 2001-2003
Completed a.Masters in Public Health during the preventive medicine residency specializing in Health Policy
and Management.
Georgetown University Washington, DC 2000-2002
Clinical Pha1macology Fellowship. Trained extensively in drug interaction, metabolism and the specialty of
drug management. Focused on Natural Products. Conducted clinical trial on effect of St. John's Wort on
CYP450 Isoenzyrnes.
Georgetown University Hospital Washington, DC 1997-2000
Resident in Pediatrics . Electives completed during residency included; Pediatric Gastroenterology, Pediatric
Infectious Diseases, Pediat11c Cardiology (Fairfax Hospital, VA), Pediatric Endocrinology (Howard
University Hospital,DC), Child Advocacy (DC Action for Children), Pediatric Development (PG Hospital,
MD), International Medicine (Mulago Hospital, Kampala, Uganda).
Temple University School of Medicine Philadelphia, PA 1993-1997
Doctor of Medicine Degree
Cornell University Ithaca, NY
Bachelors of Science Degree, majored in Nut.ritional Biochemistry.
Philadelphia High School for Girls Philadelphia, PA 1987-1989
Received High School diploma
Shaw High School Cleveland, 0 H 1985-1987
RESEARCH EXPERIENCE
Bill Gates Foundation/Johns Hopkins University Yaounde, Cameroon June-Sept. 2003
Worked with local branch of the \VI-IO and the Cameroon national vaccine program (PEV) to evaluate the
effectiveness of the country's measles infectiort surveillance system. Prov"ided recomtnendations to the
Cameroonian Ministry of Public Health and provided data to JHU to help determine the accuracy of data
generated by PEV/\XIHO. Traveled extensively through Cameroon.
Food and Drug Administration Rockville, MD Feb-Mar., 2003
Analysis of adverse events reported to VAERS for the Smallpox Vaccine from December 13, 2002-March
2003. Findings were presented to the CDC and FDA vaccine safety teams as well as to a Congressional
Subcommittee. Advisor: Robert Ball, MD.
Georgetown University Hospital Washington, DC 2001- 2003
Effect ofSt. John's Wort Extract on CYP450 Isoenzymes and Natural Product use in the Pediatric
population
Case Western Reserve School of Medicine Clevehrnd, 0 H Summer, 1992
DNA Transplarttation
Temple University School of Medicine Philadelphia, P21. Summer,1991
DNA sequencing of Retinoic Acid Binding Protein. Advisor: Diane Soprano, PhD
Temple University School of Medicine Philadelphia, P.A Summer, 1988
Replication of neonate cardiocytes using Norepinephrine Advisor: Thomas Marino, PhD.
PUBLICATIONS
Leveraging Existing Clinical Data for Extrapolation to Pediatric Uses of Medical Devices, CDRH Guidance
document, Issuance Pending Spring, 2015
http:/ /W\vw.fda.gov/ucm/groups/fdagov-public/@fdagov-1neddev-
gen/ documents/ document/ ucm444591.pdf
Pediatric Clinics of North America, Safety and Reliability in Pediatrics, "FDA working to ensure the safety of
medical devices used in the pediatric population". Volume 59, Issue 6, December 2012, Pages 1355-1366.
http://www.sciencedirect.com/science/article/pii/S0031395512001307
OTHER ACTIVITIES
Cornell Human Ecology Alumni Association Ithaca, NY 2010 to 2015
Elected in 2009 to serve as member of the Board of Directors for HE.A,-\. Participates in quarterly meetings
either on campus or by telephone to discuss issues related to the college of Human Ecology, and serving on the
committee, which reviews HE.A.A Student Grant applications.
Unity Health Care Washington, DC 2010 to 2015
Serving on the Board of Directors of Unity Health Care, which is a DC, based health care conglomerate,
which provides medical and social services to DC residents regardless of ability to pay. ~-\.ttends monthly BOD
meetings. Chair of Continuous Quality Improvement Committee since 2012)
Step Mrika! Washington, DC 2008 to date
Se.ryed on the planning committee for the Annual Home Performance Series and currently serving on the
Board of Directors as Chairperson. Served as Vice-Chair of the BOD 2010-2011 and Chair of the BOD
from 2012-2017.
FRESH Student ExtemProgram Washington, DC 2007-2010
Scheduled profe.ssional shadowing experience with current Cornell Student during academic breaks.
Cornell Alumni Student Mentoring Program 2006 to date
Virtual mentor to two currently enrolled Cornell students and three recent alumni. Visit with students either
on campus or in DC to serve as mentor and advisor. Currently Serving as mentor to S Cornell Alumni.
Mayor Fenty's Health Policy Transition Team Washington, DC 2006- 2007
Served on the Health Policy Transition team From November, 2006- February, 2007 for DC J\,1ayor Adrian
Fenty and assisted in the drafting of '~The Parameters of Health" which outlined health policy proposals and
priorities to achieve .Adrian Fenty's ''Vision for a Healthy City".
Cornell Club of Washington Washington, DC 2005-2006
Board Member
Cornell Black Alumni Associatiort Washington, DC 2004-2011
Member. Served as Reg1onal Co-Chair in 2006.
Institute for Urban Living Washington, DC 2004-2006
Member of the Board of Directors. Organization provides support services for the District's homeless
population.
College Bound Washington, DC 2001-2016
Tutot and mentor. Selected as Mentor of the Year, 2003. Nominated for 111e Washington Redskins
Community Quarterback.Award. Currently serving on the Board of Directors (2006- to date) as Board
Secretary (since 2012) . .Also serving as a virtual mentor to a college graduate.
Cornell Alumni Ambassadors Admissions Network Washington, DC 1995- to date
Inte.r view prospective applicants to Cornell and participate in college fairs.
Manuscript Reviewer Washington, DC 2001- to date
Review manuscripts on behalf of ~iichael Stein, MD for Clinical Pharmacology and Therapeutics scientific
journal.
Dream Academy Washington, DC 2000-2002
Mentor
SAT prep class instructor Philadelphia, PA 1994-1997
Big Friends Philadelphia, PA 1993-1995
Tutored third and fourth grader students
HONORS AND ACHIEVEMENTS
ODE Award of Recognition June 2017
This award recognized tireless efforts to expedite the classification of unclassified wound dressings and to
prepare for progress briefings to Center and Agency management.
ODE Award of Recognition June 10, 2017
This award recognized excellence in Agency "vide collaboration to promote safe use of soft tissue filler devices.
ODE Award of Recognition August 2016
This award r.e cognized excellence in consults and development and dissemination of policies related to devices
intended for pediatric use.
ODE Award of Recognition August 2015
This award recognized excellence in consults and regulatory support and was awarded by the ODE Office
director.
Commissioner's Award ofExcellence August, 2014
This award recognized contributions and accomplishments in conducting and executing the Pediatric Device
Consortia Grant process.
ODE Excellence in Premarket Review Team Award July 2014
This award recognized significant accomplishment in supporting the mission of CDRH in working with the
Aesthe.tic Clinical Trials Team.
CDRH Guidance/Policy/Regulation Development Excellence Award June, 2014
For excellence in writing guidance on custom devices that incorporates the requirements and revisions of the
FDA Safety and Innovations Act of 2012.
FDA Ho11or Award J1.1ne, 2014
This award recognized superior achievement of the Agency's mission through teamwork, partnership, shared
responsibility, o:r fostering collaboration and coalition to achieve FDA goals related to the planning ancl
implementation of the Rare Disease Public Workshop .
Reward and Recognition FDA/CDRH/ODE August 2011
For exceptional scientific and regulatory perfo1mance while reviewing two de novo applications.
Reward and Recognition FDA/CDRH/0D E August 2011
For exceptional scientific and regulatory performa11ce, while reviewing Contura, Inc's Aquamid Dermal Filler
PM.A.
Reward and Recognition FDA/CDRH/ODE August2011
For exceptional scientific and regulatory performance during the preparation and editing of modifications to
the Breast Implant patient and physician labels to include .ALCL information.
Reward and Recognition FDA/CDRH/ODE Sept. 2010
For exceptional scientific and regulatory perfo1mance while acting as clinical reviewer and medical advisor to
the breast implant review team for bteast implant PfvL\s and medical issues related to breast implants.
FDA Outstandiilg Service Award June, 2010
This award is in recognition of dedication to excellence in accomplishing the mission of the CDRH as a
member of the Wound Dressing Group.
Reward and Recognition FDA/CDRII/ODE Sept. 2009
For work on perfo,;ming complicated review of tiss1.1e fillers combined with the drug lidocaine.
Director's Special Citation., FDA/CDRH/OSB
Recognized for work on the launch of the KidNet pilot program June, 2008
Special Recognition Award, FDA/CDRH/OIVD
Recognition for work with the review team for Continuous Glucose Monitors June,2008
Group Recognition Award, FDA/CDRH/OSB
Recognition for work with the Collaborative Reviewers Team. June,2008
Reward and Recognition FDA/CDRH/ODE March, 2005
For medical consulting contributions to the review of In Vitro diagnostic Devices and Leadership of the
OIVD Patient Safety Team.
Bill Gates FoUildation Grant 2003
NIH Fellowship Award 2001-2002
National Minority Fellowship Award 1994-1997
Quill and Dagger Senior Honor Society 1992
Cornell Tradition Fellowship 1990-1993
Office of Minority Affairs Scholarship 1989-1993
White Williams Scholarship for In.t.ernational Affairs 1988-1989
.ADMITTING PRIVLIGES
Georgetown University Hospital and Sibley IV1emorial Hospital.
 * * *
WE ARE
oc
WASl-! INGTON
Executive Office of the Mayor - Office of Talent and Appointments
John A. Wilson Building I 1350 Pennsylvania Avenue, Suite 600 I Washington, DC 20004
Dr. Jacqueline Francis, MD
Dr. J